| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-4939-6762-9_10 |
| P698 | PubMed publication ID | 28092033 |
| P50 | author | Jeffrey J Babon | Q56882450 |
| Nicholas P D Liau | Q86251815 | ||
| P2093 | author name string | Artem Laktyushin | |
| P2860 | cites work | A family of cytokine-inducible inhibitors of signalling | Q24313168 |
| A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 | ||
| Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase | Q24314333 | ||
| Twenty proteins containing a C-terminal SOCS box form five structural classes | Q24317684 | ||
| The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop | Q24533774 | ||
| Structure of the SOCS4-ElonginB/C Complex Reveals a Distinct SOCS Box Interface and the Molecular Basis for SOCS-Dependent EGFR Degradation | Q27649020 | ||
| The SOCS Box Domain of SOCS3: Structure and Interaction with the ElonginBC-Cullin5 Ubiquitin Ligase | Q27651007 | ||
| SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition | Q27676669 | ||
| SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins | Q28131774 | ||
| Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain | Q28140535 | ||
| A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera | Q28241887 | ||
| Structure and function of a new STAT-induced STAT inhibitor | Q28584775 | ||
| Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain | Q28910199 | ||
| Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis | Q29614337 | ||
| A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 | ||
| Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses | Q33857008 | ||
| Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates | Q33857419 | ||
| Identification of an acquired JAK2 mutation in polycythemia vera | Q33947635 | ||
| Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase | Q34650624 | ||
| Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 | Q35777741 | ||
| Jaks and cytokine receptors--an intimate relationship | Q36496263 | ||
| The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression | Q37289267 | ||
| The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. | Q40289129 | ||
| Cytokine receptor signalling | Q40416594 | ||
| Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins | Q41509409 | ||
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 173-182 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies. | |
| P478 | volume | 1555 |
Search more.